Remdesivir trial Results
Drugs trial for coronavirus:- Antiviral drug Remdesivir helps patients hospitalised with Covid_19 recover faster and may also reduce mortality rate, according to the US National Institutes of Health( NIH) Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo Specifically, the median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group (P=0.059).